Doubt over Trump’s coronavirus ‘cure’
The unpublished study shows COVID-19 patients on hydroxychloroquine had a 28% death rate compared with 11% of those who did not receive it
A malaria drug touted by US President Donald Trump as a “game changer” and a “cure” in the fight against the coronavirus provided no benefit and potentially higher risk of death for patients, reports an unpublished US analysis of veteran hospital data.
The decades old hydroxychloroquine has been widely used in an attempt to alter the course of the COVID-19 respiratory illness based on anecdotal reports that it may provide some benefit.
